Leonie M. Quinn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Leonie M. Quinn has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Helena E. Richardson
Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Sciences, La Trobe University, Melbourne, Victoria, 3086, Australia
14 shared publications - Olga Zaytseva
The Australian National University
12 shared publications - Naomi C. Mitchell
Department of Anatomy and Cell Biology, University of Melbourne, Parkville 3010, Melbourne, Australia
10 shared publications - Ross D. Hannan
John Curtin School of Medical Research, Australian National University, Australian Capital Territory, Canberra, Australia
8 shared publications - Sharad Kumar
Centre for Cancer Biology, College of Health, Adelaide University, Adelaide, Australia
7 shared publications David L. Levens
National Cancer Institute, NIH 3 , Bethesda, MD 20892 , USA
5 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1854057
Drosophila glioma models: a view from the neural stem cell niche
Gliomas are the most common primary brain tumours in adults, characterised by significant cellular and molecular heterogeneity. Recent advances in molecular profiling have transformed brain tumour classification but, despite these developments, gliomas remain refractory to standard and targeted treatments. The prediction that glioma stem cells (GSCs) drive tumour initiation has focused research efforts on determining intrinsic mechanisms driving acquisition of stemness. Nevertheless, GSCs reside in a cellular environment (or stem cell niche) comprised of differentiated glioma cells, with potential to influence stemness of neighbouring GSCs. Thus, if we are to understand initiation and progression of these stem cell-driven tumours, in addition to elucidating cell intrinsic regulation of GSC fate, we must also delineate extrinsic signalling inputs from the GSC niche. For this, we require in vivo models enabling dissection of key lines of communication between GSCs and the surrounding niche. Here we provide an overview of GSC-niche modelling using Drosophila , where key mechanisms of neural stem cell control and genetic drivers of glioma are conserved. We focus on the utility of Drosophila models for modelling both intrinsic and extrinsic inputs to stem cell fate control, which have provided unique insights into the molecular and cellular basis of glioma initiation and progression.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1854057
Open AccessDrosophila glioma models: a view from the neural stem cell niche
Gliomas are the most common primary brain tumours in adults, characterised by significant cellular and molecular heterogeneity. Recent advances in molecular profiling have transformed brain tumour classification but, despite these developments, gliomas remain refractory to standard and targeted treatments. The prediction that glioma stem cells (GSCs) drive tumour initiation has focused research efforts on determining intrinsic mechanisms driving acquisition of stemness. Nevertheless, GSCs reside in a cellular environment (or stem cell niche) comprised of differentiated glioma cells, with potential to influence stemness of neighbouring GSCs. Thus, if we are to understand initiation and progression of these stem cell-driven tumours, in addition to elucidating cell intrinsic regulation of GSC fate, we must also delineate extrinsic signalling inputs from the GSC niche. For this, we require in vivo models enabling dissection of key lines of communication between GSCs and the surrounding niche. Here we provide an overview of GSC-niche modelling using Drosophila , where key mechanisms of neural stem cell control and genetic drivers of glioma are conserved. We focus on the utility of Drosophila models for modelling both intrinsic and extrinsic inputs to stem cell fate control, which have provided unique insights into the molecular and cellular basis of glioma initiation and progression.
- Open Access
Psi represses EGFR signalling in the neural stem cell niche to inhibit neuroblast proliferation in the Drosophila brain
In mammals, neural stem cells (NSCs) generate the neurons and glia essential to brain development, while defective NSCs drive brain cancer (glioma). NSC fate is not only controlled cell intrinsically, but also relies on signalling from the cellular microenvironment, or stem cell niche. Defective communication between NSCs and their niche can, therefore, drive stem cell renewal over differentiation to promote glioma. Here, we demonstrate that the orthologue of glioma-driver mutation FUBP1, Drosophila Psi, is essential in the cortex glia, the NSC niche, for preventing NSC overproliferation. We further demonstrate that Psi controls NSC fate through direct transcriptional repression of EGFR ligands, spitz (spi) and gurken (grk); with spi required cell intrinsically to enable proliferative growth of cortex glia, while grk functions cell extrinsically to control NSC fate. These observations highlight the complexity of EGFR function in modulating communication between NSCs and their niche. Our findings demonstrate the importance of understanding the nuances of intrinsic and extrinsic control of NSC fate, mechanisms of cell-cell communication critical to animal development that will provide insight into FUBP1/EGFR-driven glioma.
Open AccessPsi represses EGFR signalling in the neural stem cell niche to inhibit neuroblast proliferation in the Drosophila brain
In mammals, neural stem cells (NSCs) generate the neurons and glia essential to brain development, while defective NSCs drive brain cancer (glioma). NSC fate is not only controlled cell intrinsically, but also relies on signalling from the cellular microenvironment, or stem cell niche. Defective communication between NSCs and their niche can, therefore, drive stem cell renewal over differentiation to promote glioma. Here, we demonstrate that the orthologue of glioma-driver mutation FUBP1, Drosophila Psi, is essential in the cortex glia, the NSC niche, for preventing NSC overproliferation. We further demonstrate that Psi controls NSC fate through direct transcriptional repression of EGFR ligands, spitz (spi) and gurken (grk); with spi required cell intrinsically to enable proliferative growth of cortex glia, while grk functions cell extrinsically to control NSC fate. These observations highlight the complexity of EGFR function in modulating communication between NSCs and their niche. Our findings demonstrate the importance of understanding the nuances of intrinsic and extrinsic control of NSC fate, mechanisms of cell-cell communication critical to animal development that will provide insight into FUBP1/EGFR-driven glioma.
- Open Access
- 1 January 2025
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 12 (1) , 49-61
Structure of an ex vivo Drosophila TOM complex determined by single-particle cryoEM
Most mitochondrial precursor proteins are encoded in the cell nucleus and synthesized on cytoplasmic ribosomes. The translocase of the outer membrane (TOM) is the main protein-import pore of mitochondria, recognizing nascent precursors of mitochondrially targeted proteins and transferring them across the outer membrane. A 3.3 Å resolution map and molecular model of a TOM complex from Drosophila melanogaster, obtained by single-particle electron cryomicroscopy, is presented. As the first reported structure of a transgenic protein expressed and purified ex vivo from Drosophila, the method provides impetus for parallel structural and genetic analyses of protein complexes linked to human pathology. The core TOM complex extracted from native membranes of the D. melanogaster retina contains transgenic Tom40 co-assembled with four endogenous TOM components: Tom22, Tom5, Tom6 and Tom7. The Drosophila TOM structure presented here shows that the human and Drosophila TOM are very similar, with small conformational changes at two subunit interfaces attributable to variation in lipid-binding residues. The new structure provides an opportunity to pinpoint general features that differentiate the TOM structures of higher and unicellular eukaryotes. While the quaternary fold of the assembly is retained, local nuances of structural elements implicated in precursor import are indicative of subtle evolutionary change.
- 1 January 2025
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 12 (1) , 49-61
Open AccessStructure of an ex vivo Drosophila TOM complex determined by single-particle cryoEM
Most mitochondrial precursor proteins are encoded in the cell nucleus and synthesized on cytoplasmic ribosomes. The translocase of the outer membrane (TOM) is the main protein-import pore of mitochondria, recognizing nascent precursors of mitochondrially targeted proteins and transferring them across the outer membrane. A 3.3 Å resolution map and molecular model of a TOM complex from Drosophila melanogaster, obtained by single-particle electron cryomicroscopy, is presented. As the first reported structure of a transgenic protein expressed and purified ex vivo from Drosophila, the method provides impetus for parallel structural and genetic analyses of protein complexes linked to human pathology. The core TOM complex extracted from native membranes of the D. melanogaster retina contains transgenic Tom40 co-assembled with four endogenous TOM components: Tom22, Tom5, Tom6 and Tom7. The Drosophila TOM structure presented here shows that the human and Drosophila TOM are very similar, with small conformational changes at two subunit interfaces attributable to variation in lipid-binding residues. The new structure provides an opportunity to pinpoint general features that differentiate the TOM structures of higher and unicellular eukaryotes. While the quaternary fold of the assembly is retained, local nuances of structural elements implicated in precursor import are indicative of subtle evolutionary change.
- Open Access
- 15 January 2023
- Published by The Company of Biologists in Development
- Vol. 150 (2)
Psi promotes Drosophila wing growth via direct transcriptional activation of cell cycle targets and repression of growth inhibitors
The first characterised FUSE Binding Protein family member, FUBP1, binds single-stranded DNA to activate MYC transcription. Psi, the sole FUBP protein in Drosophila, binds RNA to regulate P-element and mRNA splicing. Our previous work revealed pro-growth functions for Psi, which depend, in part, on transcriptional activation of Myc. Genome-wide functions for FUBP family proteins in transcriptional control remain obscure. Here, through the first genome-wide binding and expression profiles obtained for a FUBP family protein, we demonstrate that, in addition to being required to activate Myc to promote cell growth, Psi also directly binds and activates stg to couple growth and cell division. Thus, Psi knockdown results in reduced cell division in the wing imaginal disc. In addition to activating these pro-proliferative targets, Psi directly represses transcription of the growth inhibitor tolkin (tok, a metallopeptidase implicated in TGFβ signalling). We further demonstrate tok overexpression inhibits proliferation, while tok loss of function increases mitosis alone and suppresses impaired cell division caused by Psi knockdown. Thus, Psi orchestrates growth through concurrent transcriptional activation of the pro-proliferative genes Myc and stg, in combination with repression of the growth inhibitor tok.
- 15 January 2023
- Published by The Company of Biologists in Development
- Vol. 150 (2)
Open AccessPsi promotes Drosophila wing growth via direct transcriptional activation of cell cycle targets and repression of growth inhibitors
The first characterised FUSE Binding Protein family member, FUBP1, binds single-stranded DNA to activate MYC transcription. Psi, the sole FUBP protein in Drosophila, binds RNA to regulate P-element and mRNA splicing. Our previous work revealed pro-growth functions for Psi, which depend, in part, on transcriptional activation of Myc. Genome-wide functions for FUBP family proteins in transcriptional control remain obscure. Here, through the first genome-wide binding and expression profiles obtained for a FUBP family protein, we demonstrate that, in addition to being required to activate Myc to promote cell growth, Psi also directly binds and activates stg to couple growth and cell division. Thus, Psi knockdown results in reduced cell division in the wing imaginal disc. In addition to activating these pro-proliferative targets, Psi directly represses transcription of the growth inhibitor tolkin (tok, a metallopeptidase implicated in TGFβ signalling). We further demonstrate tok overexpression inhibits proliferation, while tok loss of function increases mitosis alone and suppresses impaired cell division caused by Psi knockdown. Thus, Psi orchestrates growth through concurrent transcriptional activation of the pro-proliferative genes Myc and stg, in combination with repression of the growth inhibitor tok.
- Open Access
- 14 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
An increase in mitochondrial TOM activates apoptosis to drive retinal neurodegeneration
Intronic polymorphicTOMM40variants increasingTOMM40mRNA expression are strongly correlated to late onset Alzheimer’s Disease. The gene product, hTomm40, encoded in theAPOEgene cluster, is a core component of TOM, the translocase that imports nascent proteins across the mitochondrial outer membrane. We usedDrosophila melanogastereyes as an in vivo model to investigate the relationship between elevated Tom40 (theDrosophilahomologue of hTomm40) expression and neurodegeneration. Here we provide evidence that an overabundance of Tom40 in mitochondria invokes caspase-dependent cell death in a dose-dependent manner, leading to degeneration of the primarily neuronal eye tissue. Degeneration is contingent on the availability of co-assembling TOM components, indicating that an increase in assembled TOM is the factor that triggers apoptosis and degeneration in a neural setting. Eye death is not contingent on inner membrane translocase components, suggesting it is unlikely to be a direct consequence of impaired import. Another effect of heightened Tom40 expression is upregulation and co-association of a mitochondrial oxidative stress biomarker,DmHsp22, implicated in extension of lifespan, providing new insight into the balance between cell survival and death. Activation of regulated death pathways, culminating in eye degeneration, suggests a possible causal route fromTOMM40polymorphisms to neurodegenerative disease.
- 14 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Open AccessAn increase in mitochondrial TOM activates apoptosis to drive retinal neurodegeneration
Intronic polymorphicTOMM40variants increasingTOMM40mRNA expression are strongly correlated to late onset Alzheimer’s Disease. The gene product, hTomm40, encoded in theAPOEgene cluster, is a core component of TOM, the translocase that imports nascent proteins across the mitochondrial outer membrane. We usedDrosophila melanogastereyes as an in vivo model to investigate the relationship between elevated Tom40 (theDrosophilahomologue of hTomm40) expression and neurodegeneration. Here we provide evidence that an overabundance of Tom40 in mitochondria invokes caspase-dependent cell death in a dose-dependent manner, leading to degeneration of the primarily neuronal eye tissue. Degeneration is contingent on the availability of co-assembling TOM components, indicating that an increase in assembled TOM is the factor that triggers apoptosis and degeneration in a neural setting. Eye death is not contingent on inner membrane translocase components, suggesting it is unlikely to be a direct consequence of impaired import. Another effect of heightened Tom40 expression is upregulation and co-association of a mitochondrial oxidative stress biomarker,DmHsp22, implicated in extension of lifespan, providing new insight into the balance between cell survival and death. Activation of regulated death pathways, culminating in eye degeneration, suggests a possible causal route fromTOMM40polymorphisms to neurodegenerative disease.
- Open Access
- 20 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7742
MYC in Brain Development and Cancer
The MYC family of transcriptional regulators play significant roles in animal development, including the renewal and maintenance of stem cells. Not surprisingly, given MYC’s capacity to promote programs of proliferative cell growth, MYC is frequently upregulated in cancer. Although members of the MYC family are upregulated in nervous system tumours, the mechanisms of how elevated MYC promotes stem cell-driven brain cancers is unknown. If we are to determine how increased MYC might contribute to brain cancer progression, we will require a more complete understanding of MYC’s roles during normal brain development. Here, we evaluate evidence for MYC family functions in neural stem cell fate and brain development, with a view to better understand mechanisms of MYC-driven neural malignancies.
- 20 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7742
Open AccessMYC in Brain Development and Cancer
The MYC family of transcriptional regulators play significant roles in animal development, including the renewal and maintenance of stem cells. Not surprisingly, given MYC’s capacity to promote programs of proliferative cell growth, MYC is frequently upregulated in cancer. Although members of the MYC family are upregulated in nervous system tumours, the mechanisms of how elevated MYC promotes stem cell-driven brain cancers is unknown. If we are to determine how increased MYC might contribute to brain cancer progression, we will require a more complete understanding of MYC’s roles during normal brain development. Here, we evaluate evidence for MYC family functions in neural stem cell fate and brain development, with a view to better understand mechanisms of MYC-driven neural malignancies.
- Open Access
- 11 June 2020
- Published by The Company of Biologists in Development
- Vol. 147 (11)
Transcriptional repression of Myc underlies the tumour suppressor function of AGO1 in Drosophila
Here, we report novel tumour suppressor activity for the Drosophila Argonaute family RNA-binding protein AGO1, a component of the miRNA-dependent RNA-induced silencing complex (RISC). The mechanism for growth inhibition does not, however, involve canonical roles as part of the RISC; rather, AGO1 controls cell and tissue growth by functioning as a direct transcriptional repressor of the master regulator of growth, Myc. AGO1 depletion in wing imaginal discs drives a significant increase in ribosome biogenesis, nucleolar expansion and cell growth in a manner dependent on Myc abundance. Moreover, increased Myc promoter activity and elevated Myc mRNA in AGO1-depleted animals requires RNA polymerase II transcription. Further support for transcriptional AGO1 functions is provided by physical interaction with the RNA polymerase II transcriptional machinery (chromatin remodelling factors and Mediator Complex), punctate nuclear localisation in euchromatic regions and overlap with Polycomb Group transcriptional silencing loci. Moreover, significant AGO1 enrichment is observed on the Myc promoter and AGO1 interacts with the Myc transcriptional activator Psi. Together, our data show that Drosophila AGO1 functions outside of the RISC to repress Myc transcription and inhibit developmental cell and tissue growth. This article has an associated ‘The people behind the papers’ interview.
- 11 June 2020
- Published by The Company of Biologists in Development
- Vol. 147 (11)
Open AccessTranscriptional repression of Myc underlies the tumour suppressor function of AGO1 in Drosophila
Here, we report novel tumour suppressor activity for the Drosophila Argonaute family RNA-binding protein AGO1, a component of the miRNA-dependent RNA-induced silencing complex (RISC). The mechanism for growth inhibition does not, however, involve canonical roles as part of the RISC; rather, AGO1 controls cell and tissue growth by functioning as a direct transcriptional repressor of the master regulator of growth, Myc. AGO1 depletion in wing imaginal discs drives a significant increase in ribosome biogenesis, nucleolar expansion and cell growth in a manner dependent on Myc abundance. Moreover, increased Myc promoter activity and elevated Myc mRNA in AGO1-depleted animals requires RNA polymerase II transcription. Further support for transcriptional AGO1 functions is provided by physical interaction with the RNA polymerase II transcriptional machinery (chromatin remodelling factors and Mediator Complex), punctate nuclear localisation in euchromatic regions and overlap with Polycomb Group transcriptional silencing loci. Moreover, significant AGO1 enrichment is observed on the Myc promoter and AGO1 interacts with the Myc transcriptional activator Psi. Together, our data show that Drosophila AGO1 functions outside of the RISC to repress Myc transcription and inhibit developmental cell and tissue growth. This article has an associated ‘The people behind the papers’ interview.
- Open Access
Psi promotes Drosophila wing growth through transcriptional repression of key developmental networks
Psi, the sole FUSE Binding Protein (FUBP) family single stranded DNA/RNA binding protein in Drosophila , is essential for proper cell and tissue growth, however its mechanism of function remains unclear. Here we use Targeted DamID combined with RNA-sequencing to generate the first genome-wide binding and expression profiles for Psi. Surprisingly, we demonstrate Psi drives growth in the Drosophila wing through transcriptional repression of key developmental pathways (e.g. Wnt, Notch and TGFβ). Thus, Psi patterns tissue growth by directly repressing transcription of developmental growth suppressors. Analysis of direct Psi targets identified novel growth inhibitors, including Tolkin (Zinc metallopeptidase implicated in TGFβ signalling), Ephexin (Rho-GEF) and emp (CD36 scavenger receptor-related protein). Their depletion not only suppressed impaired growth associated with Psi knockdown, but alone was sufficient to drive wing overgrowth. Thus, Psi drives wing growth twofold, through direct activation of Myc and through transcriptional repression of growth inhibitors comprising core developmental pathways.
Open AccessPsi promotes Drosophila wing growth through transcriptional repression of key developmental networks
Psi, the sole FUSE Binding Protein (FUBP) family single stranded DNA/RNA binding protein in Drosophila , is essential for proper cell and tissue growth, however its mechanism of function remains unclear. Here we use Targeted DamID combined with RNA-sequencing to generate the first genome-wide binding and expression profiles for Psi. Surprisingly, we demonstrate Psi drives growth in the Drosophila wing through transcriptional repression of key developmental pathways (e.g. Wnt, Notch and TGFβ). Thus, Psi patterns tissue growth by directly repressing transcription of developmental growth suppressors. Analysis of direct Psi targets identified novel growth inhibitors, including Tolkin (Zinc metallopeptidase implicated in TGFβ signalling), Ephexin (Rho-GEF) and emp (CD36 scavenger receptor-related protein). Their depletion not only suppressed impaired growth associated with Psi knockdown, but alone was sufficient to drive wing overgrowth. Thus, Psi drives wing growth twofold, through direct activation of Myc and through transcriptional repression of growth inhibitors comprising core developmental pathways.
- Open Access
Transcriptional repression of Myc underlies AGO1’s tumour suppressor function
Here we report novel tumour suppressor activity for the Drosophila Argonaute family RNA binding protein AGO1, a component of the miRNA-dependent RNA-induced silencing complex (RISC). The mechanism for growth inhibition does not, however, involve canonical roles as part of the RISC; rather AGO1 controls cell and tissue growth by functioning as a direct transcriptional repressor of the master regulator of growth, Myc. AGO1 depletion in wing imaginal discs drives a significant increase in ribosome biogenesis, nucleolar expansion, and cell growth in a manner dependent on Myc abundance. Moreover, increased Myc promoter activity and elevated Myc mRNA in AGO1 depleted animals requires RNA Pol II transcription. Further support for transcriptional AGO1 functions is provided by physical interaction with the RNA Pol II transcriptional machinery (chromatin remodelling factors and Mediator Complex), punctate nuclear localisation in euchromatic regions and overlap with Polycomb Group transcriptional silencing loci. Moreover, significant AGO1 enrichment is observed on the Myc promoter and AGO1 interacts with the Myc transcriptional activator Psi. Together our data show AGO1 functions outside of the RISC to repress Myc transcription and inhibit developmental cell and tissue growth.
Open AccessTranscriptional repression of Myc underlies AGO1’s tumour suppressor function
Here we report novel tumour suppressor activity for the Drosophila Argonaute family RNA binding protein AGO1, a component of the miRNA-dependent RNA-induced silencing complex (RISC). The mechanism for growth inhibition does not, however, involve canonical roles as part of the RISC; rather AGO1 controls cell and tissue growth by functioning as a direct transcriptional repressor of the master regulator of growth, Myc. AGO1 depletion in wing imaginal discs drives a significant increase in ribosome biogenesis, nucleolar expansion, and cell growth in a manner dependent on Myc abundance. Moreover, increased Myc promoter activity and elevated Myc mRNA in AGO1 depleted animals requires RNA Pol II transcription. Further support for transcriptional AGO1 functions is provided by physical interaction with the RNA Pol II transcriptional machinery (chromatin remodelling factors and Mediator Complex), punctate nuclear localisation in euchromatic regions and overlap with Polycomb Group transcriptional silencing loci. Moreover, significant AGO1 enrichment is observed on the Myc promoter and AGO1 interacts with the Myc transcriptional activator Psi. Together our data show AGO1 functions outside of the RISC to repress Myc transcription and inhibit developmental cell and tissue growth.
- Open Access
- 1 August 2017
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 7 (8) , 2497-2509
A Kinome RNAi Screen inDrosophilaIdentifies Novel Genes Interacting with Lgl, aPKC, and Crb Cell Polarity Genes in Epithelial Tissues
In both Drosophila melanogaster and mammalian systems, epithelial structure and underlying cell polarity are essential for proper tissue morphogenesis and organ growth. Cell polarity interfaces with multiple cellular processes that are regulated by the phosphorylation status of large protein networks. To gain insight into the molecular mechanisms that coordinate cell polarity with tissue growth, we screened a boutique collection of RNAi stocks targeting the kinome for their capacity to modify Drosophila “cell polarity” eye and wing phenotypes. Initially, we identified kinase or phosphatase genes whose depletion modified adult eye phenotypes associated with the manipulation of cell polarity complexes (via overexpression of Crb or aPKC). We next conducted a secondary screen to test whether these cell polarity modifiers altered tissue overgrowth associated with depletion of Lgl in the wing. These screens identified Hippo, Jun kinase (JNK), and Notch signaling pathways, previously linked to cell polarity regulation of tissue growth. Furthermore, novel pathways not previously connected to cell polarity regulation of tissue growth were identified, including Wingless (Wg/Wnt), Ras, and lipid/Phospho-inositol-3-kinase (PI3K) signaling pathways. Additionally, we demonstrated that the “nutrient sensing” kinases Salt Inducible Kinase 2 and 3 (SIK2 and 3) are potent modifiers of cell polarity phenotypes and regulators of tissue growth. Overall, our screen has revealed novel cell polarity-interacting kinases and phosphatases that affect tissue growth, providing a platform for investigating molecular mechanisms coordinating cell polarity and tissue growth during development.
- 1 August 2017
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 7 (8) , 2497-2509
Open AccessA Kinome RNAi Screen inDrosophilaIdentifies Novel Genes Interacting with Lgl, aPKC, and Crb Cell Polarity Genes in Epithelial Tissues
In both Drosophila melanogaster and mammalian systems, epithelial structure and underlying cell polarity are essential for proper tissue morphogenesis and organ growth. Cell polarity interfaces with multiple cellular processes that are regulated by the phosphorylation status of large protein networks. To gain insight into the molecular mechanisms that coordinate cell polarity with tissue growth, we screened a boutique collection of RNAi stocks targeting the kinome for their capacity to modify Drosophila “cell polarity” eye and wing phenotypes. Initially, we identified kinase or phosphatase genes whose depletion modified adult eye phenotypes associated with the manipulation of cell polarity complexes (via overexpression of Crb or aPKC). We next conducted a secondary screen to test whether these cell polarity modifiers altered tissue overgrowth associated with depletion of Lgl in the wing. These screens identified Hippo, Jun kinase (JNK), and Notch signaling pathways, previously linked to cell polarity regulation of tissue growth. Furthermore, novel pathways not previously connected to cell polarity regulation of tissue growth were identified, including Wingless (Wg/Wnt), Ras, and lipid/Phospho-inositol-3-kinase (PI3K) signaling pathways. Additionally, we demonstrated that the “nutrient sensing” kinases Salt Inducible Kinase 2 and 3 (SIK2 and 3) are potent modifiers of cell polarity phenotypes and regulators of tissue growth. Overall, our screen has revealed novel cell polarity-interacting kinases and phosphatases that affect tissue growth, providing a platform for investigating molecular mechanisms coordinating cell polarity and tissue growth during development.